Corroborating our finding, Van den Abbeele and colleagues (2007) [58] demonstrated that the downregulation of gelsolin in several cancer cell types significantly reduces the invasive and motile properties of the cells, as well as cell aggregation, pointing to a role for gelsolin as tumor activator. The gene discussed is GSN; the disease is neoplasm.